RxDoctor Payments Data

Danelle Williams, MD

Family Medicine · Fort Washington, MDNPI 1558308338

Payments from drug & device makers

$1,816in general payments, 2019–2025

Across 89 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$550
  • Lilly USA, LLC$227
  • Pfizer$155
  • GSK$152
  • AstraZeneca$129
  • Merck$120
  • plus $483 from 11 others

What the payments were for

  • Food & beverage$1,816100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,816 in reported general payments places this provider in the 75th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$92,459
Medicare patients
268
Services billed
1,367

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide105$145,033
MounjaroTirzepatide32$46,904
EliquisApixaban43$40,819
JardianceEmpagliflozin19$25,123
FarxigaDapagliflozin Propanediol29$24,997
RybelsusSemaglutide11$23,083
LinzessLinaclotide17$13,666
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$8,210
Rosuvastatin Calcium190$4,521
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide37$2,689
Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med27$2,306
Atorvastatin Calcium206$2,206
Colchicine12$1,730
Amlodipine Besylate287$1,653
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp11$1,508

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$550$168,116116 claims
Lilly USA, LLCMounjaro$227$46,90432 claims
PfizerEliquis$155$40,81943 claims
Boehringer IngelheimJardiance$20$25,12319 claims
AstraZenecaFarxiga$129$24,99729 claims
AbbVieLinzess$47$13,66617 claims
GSKTrelegy Ellipta$152$8,21011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Fort Washington

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →